Neogenomics Laboratories

NeoGenomics News

10/11/2024

Important update: Hurricane Milton




We are pleased to report that our team has weathered Hurricane Milton.  Our team's coordination has ensured minimal impact to patients and to our business.  Ahead of the storm's arrival, we enacted our Business Continuity Plan and closed our Fort Myers lab Tuesday afternoon.  All specimens were rerouted to our Aliso Viejo lab.  After a full assessment this morning, we have determined there is no damage to our Fort Myers lab, and we will have reopened the Fort Myers lab.  Our analysis lab in Tampa is without power, and employees have been instructed to work from home until power is restored.


To care for our team that may have been impacted, we have set up shower and laundry stations on-site at headquarters.  Our cafeteria is preparing hot meals for teammates and their families.  We are committed to providing the resources necessary for getting back to normal.


October 9, 2024

 

New Test

NEO | AML Express™

One order. One specimen. Rapid, informed decisions.

NeoGenomics is proud to announce a new NGS-only assay for the assessment of acute myeloid leukemia (AML). NEO | AML Express provides class-leading turnaround time of 3-4 days, delivers a single report that offers a comprehensive NGS-based assessment, and aids in diagnosis, prognosis and therapy selection.

NEO | AML Express is a DNA & RNA next-generation sequencing (NGS) assay that is aligned with the latest guidelines, including the WHO 5th Edition Classification, for AML.

  • 38 genes by DNA sequencing for SNVs/InDels
  • 9 genes by RNA sequencing for fusions

Test details:

  • Specimen Requirements: bone marrow (1-2 mL) or peripheral blood (2-3 mL) in EDTA
  • Turnaround Time (TAT): 3-5 days
  • Billing: Client-Bill only
  • NYS Approval: No

IMPORTANT! To ensure fast TAT and specimen stability, please ship all orders directly to Neo Houston lab.

For more info, please contact your local NeoGenomics Territory Business Manager or visit the test menu page here.

 

Test Update

FISH

Effective Monday, October 14th, the FISH Signal Guide will be updated with the following changes.

The updated FISH Signal Guide will be available for download on NeoLINK under Documentation on October 14.

 

Test Discontinuations

 

Effective Monday, November 4th, the tests listed below will be discontinued from our menu in an effort to streamline our offerings so that you have access to the most up-to-date solutions available while still maintaining our exceptional quality and service. Alternative test options, where available, have been listed for your reference. Please visit our website for our complete directory of tests.

We thank you for your continued trust in our service to support your patient care.

 
Test to be DiscontinuedModalityAlternative Test Option(s)
ALK Mutation AnalysisMolecularNeoTYPE® DNA & RNA-LungNeo Comprehensive™ - Solid TumorNeoTYPE® Lung Tumor ProfileNeoTYPE® Discovery (NY Clients)
PIK3CA LDT Mutation Analysis by SequencingMolecularNeoTYPE® Breast Tumor ProfileNeo Comprehensive - Solid Tumor
Calcium StainAPNone
CDX2/CK7 Double StainAPCDX2 and CK7 singular stains
CK 14APNone
CK 18APNone
CK HMW/LMW Double StainAPNone
CMV (ISH)APCMV IHC
Collagen IVAPNone
ERCC1APNone
FascinAPCombination of PAX5/CD30 IHC or EBV LMP
Pneumocystis Carinii (Jiroveci)APNone
SmoothelinAP Desmin IHC
Thymidylate SynthaseAPNone
RRM1APNone
pAKTAPNone

 

 

You have exceeded the maximum number of log in attempts and your account has been locked. Please click on Forgot Password to proceed or contact Client Services at 1-866-776-5907, option 3 for assistance. Thank You.